Concepedia

Xinyi Yao

XY

Statistics

Publications

2

Citations

109

H-Index

2

Active since

2011

Affiliations

Women's Health Research Institute(Current)

Xinyi Yao is an author at Women's Health Research Institute specializing in cancer therapeutics, pathology, and medicine.

ORCID

Top concepts

Publications per year

2011–2014

2

Publications

2

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Elena Ratner, Florence K. Keane, Robert Lindner et al. · Oncogene · 2011 · 82 citations · Full text

, , +11

FINAL RESULTS OF A PROSPECTIVE MULTI-INSTITUTIONAL PHASE II STUDY OF EVEROLIMUS (RAD001), AN MTOR INHIBITOR, IN PEDIATRIC PATIENTS WITH RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA. A POETIC CONSORTIUM TRIAL

Mark W. Kieran, Xinyi Yao, Margaret E. Macy et al. · Neuro-Oncology · 2014 · 27 citations · Full text

, , +21

1–2 of 2